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Abstract 
Background: High prevalence of metabolic diseases among young professional athletes with large body sizes has 
raised growing attention. However, few studies specifically examined whether additional aerobic exercise provides 
cardiometabolic beneficial effect among these young athletes under regularly intensive strength training.
Objective: We conducted a pilot trial to evaluate the effects of aerobic exercise on overall metabolic syndrome (MetS), 
individual MetS components, and aerobic capacity among metabolically unhealthy athletes in the heaviest-weight class.
Methods: Forty-nine professional athletes aged 15–30 years had large body weights (mean weight of 131 ± 15.5 kg 
and 108 ± 15.8 kg and mean BMI of 39.4 ± 4.7 kg/m2 and 36.4 ± 5.1 kg/m2 for 26 men and 23 women, respectively). 
They completed a supervised moderate intensity (maximal heart rate: 140–170 beats/min for 30–70 min/day) aerobic 
exercise training for 12 weeks. We collected and measured metabolic parameters and aerobic capacity for all partici-
pants before and after 12 weeks of aerobic exercise training.
Results: At baseline, 42 (86 %) of all 49 metabolically abnormal athletes were diagnosed as MetS according to the 
NCEP ATP III criteria (≥3 MetS components). After aerobic exercise training, 30 % (13/42) of MetS individuals tended to 
become free of MetS (<3 MetS components), decreasing the prevalence of MetS by 30.4 % (from 17 to 10) in women 
and 23.1 % (from 25 to 19) in men (P = 0.001). All individual components of MetS, including fasting glucose levels, 
lipid profile, and blood pressure, were also significantly improved (all P-values <0.05). Overall and central obesity 
indexes, including BMI, waist circumference, Waist-hip ratio, and abdominal fat ratio, were significantly decreased 
in men whereas only overall adiposity indexes, such as BMI and body fat percentage, were significantly reduced in 
women. Also, participants’ aerobic capacities were also significantly enhanced with longer running distances and 
decreased heart rates (all P-values <0.05).
Conclusions: Our pilot trial showed that moderate intensity aerobic exercise effectively improved cardiometabolic 
parameters in metabolically unhealthy professional athletes with routinely intensive strength training. Its long-term 
cardiovascular effects will be evaluated by future randomized controlled trials with well-designed exercise modalities.
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Background
Cardiometabolic risk factors for diabetes mellitus and 
cardiovascular diseases (CVDs) have been associated 
with cardiovascular morbidity and mortality in the gen-
eral population [1]. More recently, several reports found 
that young, active, and seemingly “healthy” professional 
athletes were not free of cardiometabolic risk, especially 
those with large body sizes [2, 3]. American football play-
ers with large body sizes were found to have 52 % higher 
risk of heart disease mortality than individuals from gen-
eral population [4]. Consistently, our previous survey 
found that 261 Chinese professional athletes of strength 
sports in the heaviest-body- weight-class had much 
higher prevalence of metabolic risk factors and metabolic 
syndrome (MetS) as an entity than their counterparts at 
all other weight groups [5]. Thus, it becomes imperative 
to develop and implement effective preventive strategies 
targeting cardiovascular health among young athletes in 
the heavy-weight class.
Exercise has been widely accepted as an efficient pre-
ventive strategy for improving cardiometabolic health [6]. 
Although cardiometabolic benefits of exercise have been 
well documented, the relative effects of different types of 
exercise (aerobic or anaerobic exercise) remain uncertain 
due to sparse data [7]. A meta-analysis for 12 randomized 
clinical trials of aerobic exercise in patients with type 2 
diabetes found that aerobic exercise had greater effects 
on reduction of the glycosylated hemoglobin, BMI, maxi-
mum heart rate and rise of VO2peak than resistance exer-
cise [8]. We thus hypothesized that aerobic exercise may 
provide additional beneficial cardiovascular effects on 
its individual components of MetS and aerobic capac-
ity among professional athletes who routinely undergo 
intensive strength training, most of being anaerobic 
exercise.
We conducted a pilot trial of 12-week moderate inten-
sity aerobic exercise intervention among young active 
professional athletes in the heaviest-weight class, who 
were metabolically unhealthy (at least one of four MetS 
components with exception of abdominal obesity).
Methods
Research design and participants
This 12-week, one-arm trial targeted metabolically 
abnormal athletes in heaviest-weight class in China (from 
Hebei, Liaoning, Jilin, and Shanxi provinces). In total, 82 
athletes in the heaviest-weight class were at the Sports 
Institute for training and routinely examined for cardio-
metabolic risk factors. They were screened by the initial 
survey for eligibility. Finally, a total of 49 athletes aged 
from 15 to 30 years, 26 men and 23 women, consent to 
participate in this trial from July 2006 to December 2008. 
Of them, 36 were weightlifting athletes, 10 were judo 
athletes, and 3 were track and field throwing athletes. 
All 49 participants included in this study were currently 
professional athletes and in their off-season periods for 
physical preparation. Among them, 13 were elite athletes 
(international level) and 36 athletes were national level. 
Generally, they received 4–5 h professional training per 
day, 6  days per week. On average, each participant had 
received 7-year training. The participants were instructed 
to remain their regular training and lifestyle during the 
study. This trial protocol was reviewed and approved by 
the Institutional Review Board of China Institute of Sport 
Sciences, Beijing, China and written informed consents 
were obtained from all athletes who participated in the 
trial.
Anthropometric measurements
Anthropometric examination, physical examination, 
measure of blood lipid profile, and aerobic capacity test 
were conducted for each participant according to the 
study protocol and the corresponding information were 
collected before and after the 12-weeks exercise train-
ing. Height, weight, waist circumference, hip circum-
ference, sitting blood pressure, and body composition 
were measured by professional physicians as previously 
described in details [5]. Briefly, height, waist circumfer-
ence, hip circumference in centimeter, and weight in 
kilogram were measured with light clothes. Waist cir-
cumference was measured at the midpoint between the 
inferior costal margin and the superior border of the 
iliac crest on the midaxillary line and hip circumference 
was measured at the maximum extension of the but-
tocks. Waist-hip ratio (WHR) is anthropometric indices 
of central adiposity which was calculated by dividing the 
waist circumference by the hip circumference. BMI was 
estimated through the equation of weight/height2 (kg/
m2). Abdominal fat ratio was calculated by dividing the 
abdominal fat volume by total abdominal volume. Blood 
pressure (BP) was measured at least twice using a cali-
brated conventional mercury sphygmomanometer. For 
each participant, an average value of 2 blood pressure 
measurements at a 3-min interval was used as the final 
BP measurement. After 10 min of rest, the right-arm SBP 
and DBP were recorded in the supine position for every 
participant seated in a quiet room. Body fat percentage 
was measured by bioelectrical impedance analysis (DSM-
BIA) using the In-Body (3.0) body composition analyzer, 
which is widely used in large-scale population studies 
because of its reasonable quality, simple technology, and 
affordable price [9].
Laboratory and biochemical measurements
After 10–12  h fasting, and avoiding of smoking, drink-
ing alcoholic beverages and coffee prior to the scheduled 
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appointment, participants sat at ease and had a rest for 
5 min to prepare for the measurements. All athletes had 
their training for 6 days per week, from Monday to Satur-
day, and were at rest on Sunday. All fasting blood samples 
were collected on Monday mornings so that athletes had 
no exercise training for at least 36 h prior to their blood 
collections. Venous blood samples were drawn from an 
antecubital vein into potassium oxalate/sodium fluo-
ride anticoagulant tubes by using standard venipuncture 
methods.
Plasma glucose was determined by hexokinase method, 
with intra- and inter-assay coefficients of variations (CVs) 
of less than 2.5 and 3.5  %, respectively. Enzymatic col-
orimetric assay (Hitachi 7170A, Japan) was used for the 
measurements of triglyceride (TG), high density lipopro-
tein cholesterol (HDL-C), and low-density lipoprotein 
cholesterol (LDL-C). The intra- and inter-assay CVs were 
less than 1.5 and 3.0  %, respectively. Blood lactate was 
assayed according to an enzymatic method as described 
previously [10]. Blood samples for lactate measure were 
collected from each athlete at 5 min after his/her 12-min 
running test.
Definition of MetS
The MetS is diagnosed according to the National Cho-
lesterol Education Program Adult Treatment Panel III 
(NCEP ATP III) criteria in 2003 [11], which was defined 
by the presence of three or more of the five individual 
components listed below: (1) waist circumference for 
abdominal obesity: men ≥102  cm or women ≥88  cm; 
(2) elevated triglycerides (≥1.7  mmol/L); (3) lower 
HDL-C (men <1.04 mmol/L and women <1.03 mmol/L); 
(4) elevated BP (systolic ≥130  mmHg and/or dias-
tolic ≥85  mmHg); and (5) elevated fasting glucose 
[≥6.1 mmol/L and (or) diabetes]. Participants in this pilot 
trial were all metabolically abnormal with at least one of 
the four MetS components (with exception of abdominal 
obesity).
Assessment of aerobic capacity
We administered Cooper 12-min running test to indi-
rectly evaluate the capacity of aerobic exercise, which is 
widely adopted by researchers because of its effectiveness 
and simple availability [12, 13]. According to the standard 
guideline of 12-min running test for China’s college stu-
dents [14], the pass levels are 1600–1900  m for women 
and 2000–2300 m for men. Good and excellent levels are 
2000–2300 m and ≥2400 m for women and 2400–2700 m 
and ≥2800 m for men, respectively. During 12 min, the 
athletes tried their best to run around the 400-m athletic 
field under the supervision of a professional coach. The 
total distance of 12 min’ running was recorded for each 
athlete. The test for everyone was conducted twice in 
every other day, if the difference was greater than 5 %, the 
test would be redone on the next day, and then the mean 
of the two measurements was calculated for analyses. 
Heart rates during exercise and 5 min after exercise were 
assessed by POLAR® sports heart meter.
A supervised moderate intensity aerobic exercise training
In their routine strength training, the intensity, fre-
quency, and time of training varied across the types of 
strength sports. Routinely, they have taken a 2–3 h vig-
orous strength training (rating perceived exertion RPE: 
17–20) twice daily for 6  days per week (from Monday 
to Saturday). After the regular morning and afternoon 
strength training, an additional 30 to 70-min aerobic 
training per day was conducted by every athlete in this 
trial. A 12-week training of moderate aerobic exercise 
was conducted among all participants.
The appropriate fat-reducing exercise intensity pro-
posed by American College of Sports Medicine (ACSM) 
is 50–70  % VO2max [15]. The participants’ heart rates 
were controlled between 140 and 170 beats/min, equiva-
lent to a moderate intensity fat reduction exercises at the 
intensity between 50 and 60 % VO2max according to the 
conversion function between the heart rate and maxi-
mal oxygen uptake proposed by Astrand in 1960 [16]. 
The time of aerobic exercise was determined according 
to the actual intensity of aerobic exercise. Thirty minutes 
aerobic training was required to keep participants’ heart 
rates ≥160 beats/min; if their heart rates were between 
140 and 150 beats/min, 70 min exercise was required to 
ensure an isometric exercise. The exercise types included 
running, jogging, bicycle pedaling, and swimming. The 
whole process of the aerobic exercise training was super-
vised by qualified physical professionals to ensure the 
required intensity and duration.
Statistical analysis
The sample size was calculated based on measurements 
of HDL-C given a power of 90 % and a type I error prob-
ability of 0.05. A sample size of 10 athletes could achieve 
a power to detect a clinically significant effect on HDL-C 
by 0.15 ± 0.13 mmol/L [17]. Given a relatively high rate 
of physical injuries observed among our professional 
athletes who received both strength training and aerobic 
exercise training, we allow for a 20 % maximal withdrawal 
rate and noncompliance. As a result, at least 40 athletes 
were needed to ensure sufficient statistical power. Finally, 
we included a total of 49 athletes in this trial.
All continuous variables were presented as the 
means ±  standard deviations (SDs) for normal distribu-
tion and median and quartiles for abnormal distribu-
tion, respectively. Categorical variables were described 
as count (frequency). The changes of demographic and 
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biochemical factors between pre- and post-measure-
ments were compared using matched t-tests or related-
samples Wilcoxon signed rank tests appropriately. The 
prevalence of individual abnormal MetS components and 
the MetS (≥3), metabolically abnormal (≥2), or metabol-
ically healthy (none with the exception of obesity) were 
determined at baseline and after the trial. Chi square 
tests were used to compare the transitions in the point 
prevalence of MetS and individual MetS component 
between baseline and end of the trial for men, women, 
or both, respectively. The modifying effect by extreme 
adiposity (BMI <40 kg/m2 and ≥40 kg/m2) was tested by 
performing subgroup analysis. Level of significance was 
two-tailed  P  <  0.05 for all statistical analyses. All data 
analyses were performed using SPSS version 20 (SPSS 
Inc., Chicago, IL, USA).
Results
Basic characteristics of the study participants
As summarized in Table  1, all 49 young athletes (26 
men and 23 women) in the heaviest-weight class with 
a median age of 20  years (range 15–30) completed this 
12-week aerobic exercise training (30–70 min/day) with-
out dropout or withdrawal. These athletes had a mean 
weight of 131  kg for men and 108  kg for women (BMI 
range 27.2–49.5  kg/m2) and a mean BMI of 39.4  kg/m2 
for men and 36.4  kg/m2 for women. As expected, men 
and women apparently differed in the demographic and 
anthropometric measurements, such as age, BMI, and 
waist circumference. All participants were metaboli-
cally abnormal because they had at least one MetS com-
ponent with exception of abdominal obesity, including, 
hypertension, hypertriglyceridemia, low HDL and fasting 
hyperglycemia.
Effects of aerobic exercises on body fatness
After this short-term moderate intensity aerobic exer-
cise intervention, body fatness of athletes was moderately 
and significantly decreased. On average, body weights 
were reduced by 3.7 kg (P < 0.0001) with a reduction of 
6 % (95 % CI 0.2–1 %) in body fat percentage (P = 0.006) 
in these young active athletes. There was a significant 
sex difference in the effects of aerobic exercise on body 
weight indexes. Overall and central obesity indexes, 
including BMI, waist, WHR, and abdominal fat ratio, 
were significantly decreased in men whereas global obe-
sity indexes, including BMI and body fat percentage, 
were only significantly reduced in women.
Effects of aerobic exercises on levels of metabolic 
biomarkers and aerobic capacity
All other individual MetS-related parameters, including 
levels of BP, triglyceride, HDL, and fasting glucose, were 
also significantly improved after a 12-week aerobic exer-
cise (all P-values <0.05). Levels of TC, TG, and LDL-C 
were significantly decreased in both men and women 
athletes (all P-values <0.05) while HDL-C levels were 
significantly elevated by approximately 0.22  mmol/L in 
women (P < 0.0001) and 0.15 mmol/L in men (P = 0.001).
Aerobic exercise had a significant effect on aerobic 
capacity as a surrogate of combined physical and cardi-
orespiratory fitness for both male and female athletes. 
For women, there was significant 8 beats/min of heart 
rate measured at 5 min after exercise slower than at base-
line (from 122 ±  11  beats/min to 114 ±  15  beats/min) 
and a 284 m in the exhausted running distance in 12 min 
(from 1711 ± 132 m to 1995 ± 226 m) higher at baseline 
than after the trial. The improvement of aerobic capac-
ity were also found in men, from 1892 m (SD 260 m) at 
baseline to 2259 m (SD 256 m) and from 124 beats/min 
(SD 9 beats/min) to 118 beats/min (SD 12 beats/min) 
for heart rate after running (all P-values <0.0001). Lower 
levels of blood lactate after aerobic exercise indicated an 
enhanced physical recovery, although the change was 
marginally significant in men (P = 0.06).
Effects of aerobic exercises on MetS transition
In all, the overall prevalence of MetS decreased from 96.2 
to 73.1 % in men and from 73.9 to 43.5 % in women after 
aerobic exercise training (P  =  0.004) shown in Fig.  1. 
After aerobic exercise training for 12-week, 7/17 women 
and 6/25 men athletes with MetS (≥3 MetS components) 
at baseline transitioned to metabolically healthy (<3 
MetS components), decreasing the prevalence of MetS by 
30.4 % (from 17 to 10) in women and 23.1 % (from 25 to 
19) in men (P = 0.001) as shown in Table 1. The preva-
lence of each of five individual MetS components, includ-
ing central obesity, hypertriglyceridemia, low HDL levels, 
hypertension, and impaired fasting glucose, tended to be 
reduced by aerobic exercises in both men and women. 
However, there was only statistical significance for the 
decreased prevalence of low HDL-C prevalence from 
69.6 % at baseline to 43.5 % at the end of training among 
women (P = 0.03).
Effect modifications by BMI
These young active athletes may respond differentially to 
aerobic exercise in terms of metabolic parameters based 
on their levels of extreme obesity. Our subgroup analy-
sis stratified by two groups (BMI <40  kg/m2 and BMI 
≥40 kg/m2) as shown in the Table 2. Overall, the effects 
of aerobic exercise training on BP were more pronounced 
in the high BMI group than the low BMI group. Spe-
cifically, the decrement of SBP in high BMI group was 
fourfold higher (P  =  0.007), and the DBP change was 
twofold higher in high BMI group than those of low BMI 
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group (P =  0.09). Basal SBP and DBP between athletes 
with BMI <40 kg/m2 vs. those with BMI ≥40 kg/m2 were 
128.9 vs. 140.8 mmHg (P = 0.02) and 85.2 vs. 83.1 mmHg 
(P  =  0.06), respectively. Not all the SBP/DBP values in 
the low BMI group were normal. We further performed 
an ANCOVA test adjusted for baseline BP and found 
that the SBP lowering effect by exercise was modified by 
baseline SBP values. After aerobic exercise training, the 
Table 1 Comparison of weight, body composition and blood lipid of 49 athletes of different genders at pre-intervention 
and post-intervention
All continuous variables were presented as the mean ± SD and compared by paired sample t-tests for normal distributed variables, and median (lower quartile, upper 
quartile) and related-samples Wilcoxon signed rand tests for variables with abnormal distribution. Categorical variable was presented as n (%) and compared by 
fisher’s exact test
a The measurements were conducted 5 min after the training of aerobic exercise
Gender Measurements Pre-intervention Post-intervention P-values
Women, N = 23 BMI (kg/m2) 36.4 ± 5.1 35.3 ± 4.5 <0.0001
Body fat percentage (%) 33 ± 0.05 32 ± 0.05 0.02
Abdominal fat ratio 0.94 ± 0.09 0.95 ± 0.08 0.55
Waist circumference (cm) 104.0 ± 10.7 103.8 ± 10.6 0.13
WHR 0.92 ± 0.11 0.92 ± 0.11 0.5
SBP (mmHg) 120 (115, 130) 120 (110, 124) 0.04
DBP (mmHg) 80 (70, 90) 80 (70, 86) 0.03
TG (mmol/L) 2.64 ± 0.57 1.97 ± 0.66 <0.0001
TC (mmol/L) 4.79 (4.08, 5.68) 4.79 (4.06, 5.26) 0.01
HDL-C (mmol/L) 1.13 (0.86, 1.35) 1.35 (1.07, 1.63) <0.0001
LDL-C (mmol/L) 2.56 ± 0.74 2.43 ± 0.76 0.06
FPG (mmol/L) 5.46 (4.87, 6.21) 5.16 (4.57, 5.73) <0.0001
12-min running test (m) 1711 ± 132 1995 ± 226 <0.0001
Heart rate (beats/min)a 122.4 ± 11.2 114.4 ± 14.5 <0.0001
Blood lactate (mmol/L)a 1.57 ± 0.71 1.38 ± 0.62 0.17
Components of MetS, n (%) 0.03
 With 1 component 0 (0.0) 5 (2.2)
 With 2 components 6 (26.1) 8 (3.5)
 With ≥3 components 17 (73.9) 10 (43.5)
Men, N = 26 BMI (kg/m2) 39.4 ± 4.7 38.1 ± 4.5 <0.0001
Body fat percentage (%) 30 ± 0.05 29 ± 0.05 0.17
Abdominal fat ratio 1.03 ± 0.09 0.99 ± 0.06 0.01
Waist circumference (cm) 114.8 ± 10.5 114.3 ± 10.5 <0.0001
WHR 1.02 ± 0.15 1.01 ± 0.15 0.08
SBP (mmHg) 140 (130, 150) 135 (125, 147) 0.03
DBP (mmHg) 95 (85, 100) 90 (80, 95) 0.003
TG (mmol/L) 5.07 ± 1.99 4.17 ± 1.46 0.03
TC (mmol/L) 5.37 (4.87, 5.91) 5.19 (4.58, 5.77) 0.001
HDL-C (mmol/L) 1.09 (0.86, 1.36) 1.24 (1.02, 1.38) 0.001
LDL-C (mmol/L) 3.11 ± 0.49 2.82 ± 0.50 <0.0001
FPG (mmol/L) 5.81 (5.18, 6.89) 5.21 ± 0.61 <0.0001
12-min running test (m) 1892 ± 260 2259 ± 256 <0.0001
Heart rate (beats/min)a 123.7 ± 9.7 118.1 ± 12.3 <0.0001
Blood lactate (mmol/L)a 1.46 ± 0.64 1.22 ± 0.53 0.06
Components of MetS, n (%) 0.64
 With 1 component 0 (0.0) 2 (7.7)
 With 2 components 1 (3.8) 5 (19.2)
 With ≥3 components 25 (96.2) 19 (73.1)
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response of post-exercise heart rate at 5 min was slowed 
by 7 beats/min (P = 0.008) in the high BMI group com-
pare with the low BMI group. None of the differences 
of other measures between athletes with BMI ≥40  kg/
m2 and those with BMI <40  kg/m2 reached statistically 
significant.
Discussions
Our pilot trial of 49 metabolically unhealthy athletes in 
the highest weight class has shown that 30–70  min/day 
moderate intensity aerobic exercise for 12  weeks elic-
ited a significantly meaningful improvement in levels of 








































































































Fig. 1 The sex-stratified prevalence of metabolic syndrome and its components before and after aerobic exercise treatment. The empty bars 
represented the pre-treatment values and the black bars represented the post-treatment values. Metabolic syndrome and its individual factors were 
defined by NCEP ATP III. The cutoff points are as follows: waist circumference for central obesity: men ≥102 cm, women ≥88 cm; hypertension: SBP/
DBP ≥130/85 mmHg; FPG ≥6.1 mmol/L, and (or) diabetes; TG ≥1.7 or HDL-C <1.04 mmol/L (men) or 1.30 mmol/L (women). *P value compared the 
difference of the prevalence of participants having low levels of HDL-C at pre- and post-training in women; #P-values compared sex differences of 
the prevalence of metabolic syndrome and its components were <0.05
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capacity. Significantly, aerobic exercise training for 
12 weeks resulted in a 20 % increment of blood HDL-C 
levels and nearly 24 % reversion from MetS to MetS-free 
status. Aerobic exercise training also improved exercise 
capacity as well as physical or cardiorespiratory fitness 
among these young athletes in heaviest-weight class. 
Despite its short-term and relatively small sample sizes, 
this pilot trial provided some encouraging empirical data 
that support the tremendous potential to implement aer-
obic exercise programming into professional athletes to 
prevent MetS-associated cardiovascular outcomes, pri-
marily due to their large body size and fatness.
MetS is defined by a constellation of risk factors of 
cardiovascular disease, which might contribute to about 
twofold increase in the risk of developing CVDs and 
fivefold increase in the risk of type 2 diabetes mellitus in 
future among general population [18]. Previously, elite 
athletes were always identified as the symbol of physical 
health because of their young ages, heavy training loads, 
large cardiorespiratory capacity, and regular participation 
of competitions during their sports careers [19, 20]. How-
ever, in 1994, a study of retired National Football League 
players found a 52 % greater risk of cardiovascular death 
in linemen with large body weights than the general 
population and 3 times higher risk of dying from cardio-
vascular diseases than non-linemen [21]. Recently, high 
incidences of obesity, metabolic syndrome, and other 
cardiovascular risk factors were also found in young col-
legiate football linemen [22–24]. Similarly, our previous 
study reported a MetS prevalence of 89 and 47 % among 
male and female Chinese active strength athletes in the 
highest weight class compared with a prevalence of 18 
and 0 % in their respective counterparts at other weight 
classes [5].
MetS is increasingly present in young professional ath-
letes with large body weights and it could greatly increase 
risk of MetS-associated chronic diseases. Exercise is an 
effective approach recommended by current guidelines for 
both primary and secondary prevention of MetS and CVDs 
[18]. Previous evidence suggested that exercise improves 
lipid profiles, reduces body fatness accumulation, lower BP 
and blood glucose levels through its underlying pleiotropic 
mechanisms [25, 26]. A meta-analysis has shown that aero-
bic exercise led to a reduction of approximately 2 % in total 
cholesterol, 3 % in LDL-C, and 5 % in TG, and an increase 
of 3  % in HDL-C [27]. In our study, most of the cardio-
metabolic biomarkers were improved and HDL-C was 
increased pronouncedly by the 12-week moderate intensity 
aerobic exercise training. Similarly, Dalleck et al. found that 
moderate aerobic exercise (60  % of heart rate) increased 
HDL-C levels in healthy obese adults [28]. Additionally, 
we also found that athletes with higher BMI tend to have 
more significant changes of cardiometabolic risk factors 
in response to aerobic exercise intervention. We classi-
fied all athletes into two subgroups by using a BMI cutoff 
point of 40 kg/m2. This BMI cutoff point is only used for 
classifying their body sizes among obese athletes but not 
for assessing adiposity. The main purpose of such a sub-
group analysis was to assess metabolic parameters among 
these heavy-weight class athletes with different body sizes. 
After we adjusted the baseline BP, the effects of exercise on 
SBP were still more pronounced in the high BMI group, but 
the difference of changes in DBP was marginally significant 
between these two BMI groups. It remains controversial 
regarding which type and intensity of exercise is optimal 
for cardiometabolic health. The appropriate fat-reducing 
exercise intensity proposed by American College of Sports 
Medicine (ACSM) is 40/50 to 70  % VO2max [15], with a 
140–170 beats/min heart rate. Aerobic exercise is a type of 
lower to moderate intensity physical activity (60–85  % of 
the maximum heart rate), which promotes increased use 
of oxygen in order to improve the overall body condition. 
Aerobic exercise promotes the activation of  various anti-
inflammatory functions, which, in turn, may reduce the 
risk of developing inflammation related chronic diseases, 
such as hypertension, type 2 diabetes, and cardiovascular 
disease [29]. Collectively, several meta-analyses of 15–54 
randomized controlled trials among patients or healthy 
populations have suggested that ≥30  min/session aerobic 
exercise for 4–104 weeks provided a moderate decreasing 
effects on lipid levels (decrement: 2 % for TC, 3 % for LDL-
C, and 5 % in women and 9 % in men for TG), weight loss 
Table 2 Measurement changes (post-treatment minus   
pre-treatment) by different baseline
BMI classes among All 49 athletes
a Continuous variables were presented as the means ± standard deviations; the 







Body fat percentage (%) 0.0009 ± 0.04 −0.05 ± 0.08 0.03
Abdominal fat ratio 0.0009 ± 0.04 −0.05 ± 0.08 0.03
Waist circumstance (cm) −0.35 ± 0.73 −0.51 ± 0.77 0.45
WHR 0.0009 ± 0.01 0.01 ± 0.01 0.65
SBP (mmHg) −1.82 ± 4.85 −7.56 ± 7.01 0.01
DBP (mmHg) −1.97 ± 4.33 −4.31 ± 4.85 0.09
TG (mmol/l) −0.89 ± 1.71 −0.58 ± 1.19 0.51
TC (mmol/l) −0.11 ± 0.27 −0.21 ± 0.17 0.18
HDL-C (mmol/l) 0.21 ± 0.38 0.21 ± 0.45 0.95
LDL-C (mmol/l) −0.18 ± 0.3 −0.29 ± 0.35 0.29
FPG (mmol/l) −0.44 ± 0.61 −0.76 ± 0.79 0.12
12-min running test (m) 309 ± 190 367 ± 218 0.35
Heart rate (beats/min) −4.3 ± 9.2 −11.8 ± 7.8 0.01
Blood lactate (mmol/l) −0.22 ± 0.65 −0.22 ± 0.59 0.98
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(decreasing weight: 1.7 kg, circumference: 2.12 cm), and BP 
(−3.84 mmHg for SBP, −2.58 mmHg for DBP) [26, 27, 30–
33]. Taking together, these data recommend aerobic exer-
cise of 2–5 session/week for 20–60 continuous minutes at 
a moderate intensity of 40–90 % of maximum heart rate for 
cardiovascular health in the general population [27].
Athletes in the highest weight class usually undertake 
intensive strength training, the necessary amount and 
intensity of aerobic exercise to improve their cardio-
metabolic health has not been described. Some evidence 
suggested that aerobic exercise was more beneficial than 
resistance  exercise  on improving glycemic control in 
patients with type 2 diabetes; glycosylated hemoglobin 
levels of patients with aerobic exercise were reduced by 
1.97  mmol/mol as compared to resistance exercise [8]. 
Nevertheless, lack of sufficient evidence to confirm the 
clinical importance of these statistical improvements 
[8, 34, 35]. The findings from our pilot trial provided 
suggestive evidence that aerobic exercise might pro-
vide additional cardiovascular beneficial effects among 
professional athletes who already received of intensive 
strength training. Since all participants were professional 
strength-trained athletes, our results may not be gener-
alizable to other athletes or the general population. Due 
to our pilot trial design without randomly assigned com-
parison groups, our study cannot assess the cardiometa-
bolic effects by aerobic exercise versus strength exercise. 
Future long-term comprehensive studies focusing on the 
appropriate types and intensity of exercise are warranted.
Several limitations in the present study should be con-
sidered. First, this trial was not a randomized controlled 
trial and lacked randomization and blind design, which 
can allow for minimizing bias and confounding over the 
trial duration. Second, the 12-week duration is relatively 
short. The results cannot be drawn on the long-term 
effect of aerobic exercise, although we observed a trend 
towards an improvement in MetS risk factors. Third, the 
sample size of 49 athletes was small to provide sufficient 
power for detecting a clinically significant transition of 
MetS and exploring potential effect modifiers. Fourth, 
there may exist residual confounders such as lifestyle 
and dietary status, although lifestyle and dietary pat-
terns were similar because the professional Chinese ath-
letes enrolled in this study lived in closed and standard 
training facilities with a strict ban on cigarette smoking 
and alcohol drinking. Fifth, there was lack of more accu-
rate measures to evaluate body composition (body fat 
and lean body mass) and some metabolic biomarkers, 
such as those of adipokines and systemic inflammation. 
Sixth, we used Cooper 12-min running test to indirectly 
evaluate the capacity of aerobic exercise although this 
test is not an optimal measurements for capacity of exer-
cise. Seventh, we only tested absolute HR value 5  min 
after exercise and did not test 1  min heart rate recov-
ery. Finally, we assumed that baseline levels of exercise 
training of athletes were equivalent, although there may 
have some differences of regular training in intensity and 
amounts among these athletes in the highest weight class.
Conclusion
In summary, our pilot trial showed that a 12-week super-
vised moderate intensity aerobic exercise training pro-
vided additional beneficial effects on cardiometabolic 
risk factors and exercise capacity among 49 metaboli-
cally abnormal athletes in the heaviest weight class who 
received intensive strength training. Our findings indi-
cate that aerobic exercise training could be considered as 
an effective model for improving cardiometabolic health 
in professional athletes, especially those at high risk, 
although future long-term and large-scale randomized 
controlled trials with well-designed exercise modali-
ties are warranted to evaluate long-term cardiovascular 
effects of exercise.
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